期刊文献+

维持性血液透析患者钙磷代谢紊乱分析 被引量:5

Analysis of calcium-phosphorus metabolism disorder in maintenance hemodialysis patients
原文传递
导出
摘要 目的分析维持性血液透析患者钙磷代谢紊乱情况。方法对70例维持性血液透析患者的钙、磷浓度、钙磷浓度乘积及甲状旁腺素(PTH)进行测定,并与K/DOQI指南指标进行比较。结果70例患者中,≥50岁36例,〈50岁34例,两组血清钙、磷浓度及钙磷乘积、PTH水平比较,差异均无统计学意义(均P〉0.05);透析时间越长,患者血清磷、PTH水平改变越明显,差异有统计学意义(均P〈0.05);70例中有46例(65.7%)血清钙、34例(48.6%)血清磷、40例(57.1%)钙磷乘积、28例(40%)PTH浓度达到K/DOQI指南要求,仅有18例(25.7%)患者所有指标达到K/DOQI要求。结论多数血液透析患者钙磷代谢控制仍然达不到K/DOQI要求的目标。 Objective To analyze the disorder status of calcium-phosphorus metablism in maintenance hemodialysis patients. Methods Serum calcium, serum phosphorus, calcium-phosphorus product and PTH were detected in 70 patients with maintenance hemodialysis, and compared with the indicators of K/DOQI guidelines. Results There were 36 cases over 50 years age and 34 cases less than 50 years age in 70 cases, and there were no significant differences in serum calcium, serum phosphorus, calcium-phosphorus product and PTH between two groups (P 〉 0. 05 ). The longer the dialysis, the more obvious changes of serum phosphorus and PTH levels, and there were significant differences (P 〈 0. 05 ). In 70 cases ,46 cases (65.7%) serum calcium ,34 cases (48.6%) serum phosphorus ,40 cases(57. 1% ) calcium and phosphorus product ,28 cases( 40% ) PTH met the requirement of K/DOQI guidelines, only 18 cases(25.7% ) of all indicators reached the K/DOQI requirements. Conclusion The calcium-phosphorus metablism in most hemodialytic patients still cannot reach the K/DOQI guidelines.
出处 《中国基层医药》 CAS 2010年第8期1059-1061,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 肾透析 甲状旁腺功能亢进 继发性 钙磷代谢 Renal dialysis Hyperparathyroidism, secondary Calcium-phosphorus metabolism
  • 相关文献

参考文献15

  • 1Block GA,Port FK.Re-eraluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients.Recommendations for a change in management.Kidney KIS,2000,35(6):1226-1237.
  • 2Eknoyan G,Levin A,Levin NW.Bone metabolism and disease in chronic kidney disease.Kidney DIS,2003,42 (2):197-201.
  • 3Block GA,Hulbert-Shearon TE,Levin NW,et al.Association of serum phosphorus and calcium phosphate product with mortality risk in chronic hemodialysis patients.A national study.Kidney DIS,1998,31 (4):607-617.
  • 4Kim J,Danese S,Satayathum P,et al.Achievement of proposed NKF-K/DOQI bone metabolism and disease guidelines:Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).Soc Nephrol,2003,14(11):269A-270A.
  • 5陈华蓉,凌庆,李亚.尿毒症透析患者不同剂量钙三醇治疗继发性甲状旁腺功能亢进的疗效观察[J].中国基层医药,2008,15(6):933-934. 被引量:7
  • 6孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:63
  • 7陈孟华.透析患者的钙磷代谢紊乱与钙化性血管病[J].中国血液净化,2009,8(10):529-532. 被引量:20
  • 8Raggi P,Boulay A,Chasan-Taber S,et al.Cardiac calcification in adult hemodialysis patients.A link between endstage renal disease and cardiovascular disease? Coll Cardiol,2002,39 (20):695-701.
  • 9Masho Y,Shigematsu T.Arteriosclerosis and vascular calcification in chronic kidney disease(CKI) patients.Clin Calcium,2007,17(4):354-359.
  • 10Goodman WG,Goldin J,Kuizon BD,et al.Elashoff RM,Salusky IB:coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.N Engl J MED,2000,342(20):1478-1483.

二级参考文献80

共引文献102

同被引文献55

  • 1蒋艳丽.慢性肾功不全尿毒症患者血液透析前后血清微量元素的改变[J].医学综述,1995,1(8):363-365. 被引量:2
  • 2范文奎,杨红,陈光贤,周少雄,梁艳影,高爱华.高通量血液透析对血清钙、磷和甲状旁腺素的影响[J].实用医学杂志,2006,22(1):24-26. 被引量:14
  • 3顾一峰,卫刚,江玉贞,王蔚琼.不同年龄维持性血液透析患者透析效果和营养状态分析[J].中国血液净化,2006,5(1):51-52. 被引量:5
  • 4LveyJ,MorganJ,BrownE.牛津临床透析手册[M].王梅,译.2版.北京:人民卫生出版社,2006:161.
  • 5Couttenye MM, D' Haese PC, Versehoren WJ, et al. Low bone turnover in patients with renal failure [J]. Kidney Int Suppl, 1999,73 : S70-S76.
  • 6Muesi I, Herez G. Relative hypoparathyroidism and adynamie bone disease [ J ]. Am J Med Sci, 1999,317 ( 6 ) :405-409.
  • 7Friedman PA, Goodman WG. PTH( 1-84 )/PTH (7-84) : a balance of power [ J ]. Am J Physiol Renal Physiol, 2006,290 ( 5 ) : F975- 984.
  • 8Guh JY, Chen HC, Chuang HY, et al. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients [ J ]. Am J Kidney Dis,2002,39(6) :1245-1254.
  • 9Kansal S, Fried L. Bone disease in elderly individuals with CKD [J]. Adv Chronie Kidney Dis,2010,17(4) :e41-e51.
  • 10Almeida M, Han L, Martin-Millan M, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids [ J ]. J Biol Chem,2007,282 ( 37 ) : 27285-27297.

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部